CASP3 and prostate carcinoma: In the present study, we revealed that BITC effectively reduces the viability of prostate cancer cells, similar to other cellular systems [26, 38–41], via the induction of apoptosis, which is involved in the disruption of the MMP, the activation of caspase 3/7 and an increase in DNA fragmentation (Figure 1).